Management of upper and lower limb spasticity in neuro-rehabilitation

Acta Neurochirurgica, Supplement

Volumn 79, Issue , 2001, Pages 117-122

  Hesse, Stefan ^a  

^a Klinik Berlin   (Germany)

Author keywords

Botulinum toxin; Spasticity; Task specific therapy

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ARM; HUMAN; LEG; PHYSIOTHERAPY; REVIEW; SPASTICITY;

ARM; BOTULINUM TOXIN TYPE A; HUMANS; LEG; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; PHYSICAL THERAPY MODALITIES;

EID: 0036010372     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6105-0_26     Document Type: Article

References (3)

1. Artieda J, Quesada P, Obeso JA (1991) Reciprocal la inhibition in spastic hemiplegia. Neurology 41:286-289
2. Bakheit AM, Thilmann AF, Ward AB, Poeve W, Wissel J, Muller J, Benecke R, Collin C, Muller F, Ward CD, Neumann C (2000) A randomized, double-blind, placebo-controlled, doseranging study to compare the efficacy and safety of three doses of Botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke. Stroke 31: 2402-2406
3. Burbaud P, Wiart L, Dubos JL, Gaujard E, Debeillex X, Joseph PA, Mazaux JM, Bioulac B, Barat M, Lagueny A (1996) A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. J Neurol Neurosurg Psychiatry 61: 265-269